NANOMED Presentation

NANOMED Presentation

The Nanomedicine for Drug Delivery (NANOMED) Master’s degree is a 24-months curriculum offering a high quality and multidisciplinary education in the emerging field of Nanomedicine. The design of nanomedicines for drug delivery requires combining knowledge from Pharmacy, Biology, Chemistry, Medicine, Physics, and Engineering. Thus four European Universities have brought together their expertise in Nanomedicine to create a unique and comprehensive training programme: Paris Descartes University (coordinator, France), Patras University (Greece), Pavia University (Italy) and Angers University (France).

Moreover, renowned experts in the field of Nanomedicine coming from academia and industry are also involved as guest Lecturers or invited Professors. The curriculum provides both theoretical and practical knowledge for 3 semesters combined with a 6-months traineeship. Application requirements will include the completion of a Bachelor’s degree in Pharmacy, or (under special provisions) in Medicine, Chemistry, Biology, Biotechnology, Chemical Engineering, Biochemistry, Material Sciences or other adequate discipline. English language proficiency is a main requirement.

What is an EMJMD?

Erasmus Mundus Joint Master Degrees (EMJMDs) are highly integrated study programmes that are delivered by an international consortium of Higher Education Institutions. They aim at fostering excellence, innovation, and internationalisation in Higher Education Institutions. The EMJMDs are supported by the EACEA (Education, Audiovisual and Culture Executive Agency) of the European Commission and are part of the Erasmus + programme.

NANOMED is gathering four European Universities (Paris Descartes University – France, Pavia University – Italy, Angers University – France, Patras University – Greece) to provide an excellent curriculum about drug delivery for Nanomedicine. Students completing the 120 ECTS-programme will thus be awarded at least 2 diplomas from the partner Universities of NANOMED he attended during the curriculum. All four funding members of the NANOMED programme are working together in order to obtain mutual recognition and thus be able to deliver all four diplomas to every student completing the curriculum.
Students applying to NANOMED may apply to EMJMD scholarships.

What is Nanomedicine?

Nanomedicine is the application of Nanotechnology (materials with sizes in the nanometre range, i.e. 10-9 m) to promote innovation in Healthcare. Nanomedicine is a revolutionary interdisciplinary science, which combines knowledge from Pharmacy, Physics, Biology, Chemistry and Medicine to treat conditions and diseases of the human body at a molecular level. Nanomedicine has many applications, from drug therapy and diagnostics to individual cell repair, to artificial tissues and radiation therapy. Our NANOMED curriculum is focusing on the drug delivery applications of Nanomedicine.

NANOMED objectives

Given the present and future challenges of unmet medical needs and health issues in a European and global perspective, there is a huge expectation on innovative approaches such as Nanomedicine in the fields of therapy, diagnosis and theranostic (combination of therapy and diagnosis).

Europe must be a competitive arena for the development and successful implementation of new sustainable medicine/therapies based on nanosystems, contributing to a better life for Europe’s population and creating opportunities in the field of life sciences. One of the major needs is to develop new International curriculums at the MsC level as identified by the European Technology Platform for Nanomedicine (ETPN) in the report entitled “Education and Training Needs in Nanomedicine”.

 

This report evidenced that there is currently an unmet need for an International training in the application of Nanomedicine to drug delivery within the European Master’s programme.

The NANOMED EMJMD (Nanomedicine for Drug Delivery) aims at filing the gap between basic training in Drug Delivery currently provided by most Schools of Pharmacy at the Master’s level, and advanced knowledge in Nanomedicine required for post-graduate young scientists. The NANOMED graduates will thus understand and be able to integrate the advances in Nanotechnology towards the development of Advanced Particulate Drug Delivery Systems.

Due to the very rapid development of new knowledge in the area of Nanotechnology, and fast adaptation of this knowledge for the development of advanced drug delivery systems, four European Universities have combined their expertise in their respective domains of Nanomedicine to create this curriculum. The consortium is bringing together experts exhibiting numerous years of research in the design of particulate drug delivery systems such as:

  • Polymeric Nanoparticles (Karine Andrieux, Paris Descartes),
  • Liposomes (Sophia Antimisiaris, Patras),
  • Polymeric Micelles and Polysaccharide Nanoparticles (Carla Caramella, Pavia),
  • Lipid Nanoparticles (Emilie Roger, Angers).

Back to Top